Application Note: KAPA RNA HyperPrep

Implementing Rapid Microbial Methods for Mycoplasma Detection

Whitepaper covers lessons learned throughout Bionique’s experience with guiding sponsors through the process of developing and qualifying or validating a MycoSEQ-based rapid mycoplasma testing strategy.

In this white paper, you’ll learn the importance of demonstrating product-specific suitability, defining representative sample, consistent sampling protocols, accommodating volume and turnaround time constraints, and the need to establish equivalence. Rapid microbial methods are increasingly being used by cell therapy developers motivated by particularly short production schedules and product shelf life, and has grown to include raw material providers interested in reducing inventory hold times.

Download Now →
View online
To ensure delivery to your inbox,
please add to your address book.
Follow American Pharmaceutical Review: Twitter   |   Facebook
This information is being brought to you because you are a subscriber to American Pharmaceutical Review
Manage your Subscription  |  Unsubscribe  |  Contact Us
395 Oyster Point Blvd, Suite 300, South San Francisco, CA 94080 USA